Somac Control (pantoprazole)
- Region
- 🇪🇺 EU
- Active substance
- pantoprazole
- Company
- Takeda GmbH
- Status
- Authorised
- Therapeutic area
- Gastroesophageal Reflux
- CHMP opinion
- Thu 19 Feb 2009
- EU approval
- Fri 12 Jun 2009
- Application
- EMEA/H/C/001098
- ATC
- A02BC02
- Official record
- www.ema.europa.eu
Indication
Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Pantozol Control Authorised · Takeda GmbH
- 🇪🇺 Controloc Control Authorised · Takeda GmbH
- 🇪🇺 Pantoloc Control Withdrawn · Takeda GmbH
- 🇪🇺 Pantecta Control Withdrawn · Takeda GmbH
Follow Somac Control
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.